Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial

Lancet Infectious Diseases
Feb 2020 Volume 20 Number 2 p145-260, e26-e62
http://www.thelancet.com/journals/laninf/issue/current

 

Article
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial
Firdausi Qadri, et al
Open Access